Background: Increasing data indicates treatment with beta blockers improves survival after traumatic
brain injury (TBI). Although the optimal heart rate (HR) to reduce mortality for trauma
patients assumes a lower heart rate is better, no study exists that demonstrates the
optimal HR for mortality reduction after isolated moderate to severe TBI. Hypothesis: Mortality is reduced for a specific heart rate range in patients with isolated TBI.
Patients and Methods: The Los Angeles County Trauma System Database, consisting of 5 Level I and 8 Level
II trauma centers, was queried for all injured patients admitted between 1998 and
2005 (n=147,788). Moderate to severe isolated head injured patients (head AIS ≥3, all other
≤3) were then identified. Patients who were dead on arrival, with head AIS=6, or had any missing data were excluded. Demographics and outcomes were compared
at various heart rate ranges (<50, 50-59, 60-69, 70-79, 80-89, 90-99, 100-109, ≥110).
Logistic regression was performed to determine significant risk factors for mortality.
Results: After exclusions, a total of 11,977 moderate to severe isolated TBI patients were
then analyzed. Mortality for all HR was 11.5%; heart rate 80-89 was identified as
having the lowest mortality (7.3%). HR 80-89 had significantly lower mortality compared
to all other HR ranges except 90-99 and 100-109. The table below demonstrates the
OR for death for each HR subgroup compared to HR 80-89. Conclusion: The optimal HR after isolated moderate to severe TBI is 80 to 109; a trend or significant
decrease in mortality was demonstrated HR 80 to 89. The 80 to 89 HR range could serve
as the target of therapeutic goals for beta blockade after TBI. Alternatively, parameters
for preexisting beta blockade therapy may require hold orders for HR less than 80
as mortality almost doubled when HR reduced to the 60s.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Surgical ResearchAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
58.5
Identification
Copyright
© 2010 Elsevier Inc. Published by Elsevier Inc. All rights reserved.